Paul Van Veldhoven
- Clinical Biochemistry top 1%
- Metabolism and Genetic Disorders 7
- Cancer Research top 5%
- Biochemistry top 5%
- Molecular Biology top 10%
- Peroxisome Proliferator-Activated Receptors 14
- RNA regulation and disease 2
- RNA modifications and cancer 2
- Physiology top 10%
- Adipose Tissue and Metabolism 5
- Adenosine and Purinergic Signaling 2
-
- Neuroscience and Neuropharmacology Research 4
-
- Muscle metabolism and nutrition 2
In The Last Decade
Paul Van Veldhoven
25 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Clinical Biochemistry 292
- Cancer Research 323
- Biochemistry 139
- Molecular Biology 1.0k
- Physiology 265
Countries citing papers authored by Paul Van Veldhoven
This map shows the geographic impact of Paul Van Veldhoven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Van Veldhoven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Van Veldhoven more than expected).
Fields of papers citing papers by Paul Van Veldhoven
This network shows the impact of papers produced by Paul Van Veldhoven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Van Veldhoven. The network helps show where Paul Van Veldhoven may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul Van Veldhoven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 1 | |
| 2 | 2011 | 49 | |
| 3 | 2011 | 11 | |
| 4 | 2010 | 15 | |
| 5 | 2007 | 45 | |
| 6 | 2006 | 38 | |
| 7 | Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature micebreakdown → | 2002 | 590 |
| 8 | 2001 | 10 | |
| 9 | 2001 | 170 | |
| 10 | Adenovirus-mediated gene transfer of human PAF-AH prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apoE-deficient mice | 2001 | 1 |
| 11 | 2000 | 4 | |
| 12 | 2000 | 46 | |
| 13 | 1998 | 2 | |
| 14 | 1998 | 177 | |
| 15 | 1989 | 42 | |
| 16 | 1984 | 16 | |
| 17 | 1984 | 94 | |
| 18 | 1982 | 104 | |
| 19 | 1982 | 10 | |
| 20 | 1982 | 56 |
About Paul Van Veldhoven
Paul Van Veldhoven is a scholar working on Clinical Biochemistry, Physiology and Molecular Biology, having authored 25 papers that have together received 1.6k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (14 papers), Metabolism and Genetic Disorders (7 papers), Adipose Tissue and Metabolism (5 papers), Neuroscience and Neuropharmacology Research (4 papers), RNA regulation and disease (2 papers), Muscle metabolism and nutrition (2 papers), Adenosine and Purinergic Signaling (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Clinical Biochemistry (292 citations), Cancer Research (323 citations) and Biochemistry (139 citations). Paul Van Veldhoven has collaborated with scholars based in Belgium, France and Germany. Frequent co-authors include G P Mannaerts, Luc J. Debeer, Désiré Collen, Peter Carmeliet, Peter Hoet, Marc Tjwa, Veerle Compernolle, Benoît Nemery, Koen Brusselmans and Karl H. Plate. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.